相关实验视频

Updated: Jan 11, 2026

Genome-wide Analysis of HDAC Inhibitor-mediated Modulation of microRNAs and mRNAs in B Cells Induced to Undergo Class-switch DNA Recombination and Plasma Cell Differentiation

Genome-wide Analysis of HDAC Inhibitor-mediated Modulation of microRNAs and mRNAs in B Cells Induced to Undergo Class-switch DNA Recombination and Plasma Cell Differentiation

Published on: September 20, 2017

收缩:阿斯特拉加洛西德IV通过调节HDAC来降低OxLDL诱导的BNP过度表达

Journal Of Healthcare Engineering

Journal of healthcare engineering

|November 11, 2025

概括

这项研究已被撤回. 标识DOI 10.1155/2021/3433615的文章不再被认为是有效的科学文献.

科学领域:

科学的撤回科学的撤回
图书统计学图书统计学
学术传播学术交流

背景情况:

文章DOI 10.1155/2021/3433615已经被撤回.
撤回对于保持科学完整性至关重要.

研究的目的:

正式宣布该文章的撤回.
通知科学界关于该研究无效的通知.

主要方法:

发布了正式的撤回通知.
由其数字物体标识符 (DOI) 识别的物品.

主要成果:

这篇文章DOI: 10.1155/2021/3433615 正式撤回.
文章的调查结果和结论无效.

结论:

撤回的文章不应该被引用或引用.
保持准确的科学记录是必不可少的.

更多相关视频

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

Published on: November 17, 2018

Investigating the Protective Effects of Platycodin D on Non-Alcoholic Fatty Liver Disease in a Palmitic Acid-Induced In Vitro Model

Investigating the Protective Effects of Platycodin D on Non-Alcoholic Fatty Liver Disease in a Palmitic Acid-Induced In Vitro Model

Published on: December 2, 2022

相关概念视频

Atherosclerosis III: Management

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...